Skip to main content
Premium Trial:

Request an Annual Quote

A Year Ago: Mar 1, 2004

Premium

A year ago in Genome Technology, Raju Kucherlapati of the Harvard Partners genome center graced our cover for an article about the phasing out of smaller sequencing centers in favor of the Big Three — Washington University, Baylor, and Whitehead (now the Broad Institute). In the year since, more of these centers have shifted their focus away from pure sequencing and are working on finishing, comparative genomics, and evolutionary genomics, among other endeavors. The biggies, meanwhile, have continued cranking away on their genome projects. Just a few of the organisms underway at those places in the last year: chicken, chimp, honey bee, dog, and cow.

In the meantime, Eric Lander received a pledge of $100 million over the next 10 years from philanthropists Eli and Edythe Broad to start and direct the Broad Institute, an interdisciplinary effort among MIT, Harvard, and the Whitehead Institute. And Graham Scott, who appeared in the March ’03 issue representing Baylor, has since moved to Sigma-Aldrich, as you’ll read on p. 11 of this issue.

Another article last year looked at the growing struggle to get visitor visas for foreign scientists trying to attend conferences in the US. The problem hasn’t been resolved as visas still take longer to process. At this year’s Plant and Animal Genome conference in San Diego, organizers estimated that 150 people had missed the show because of troubles trying to attain a visa.

A news item last year noted the continued growth of IBM’s life sciences unit. That proved to be critical to the company, which has in the past year launched an information-based medicine unit on the same model it used to start the life sciences group. You’ll find BioInform editor Bernadette Toner’s explanation of that on p. 42.

 

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.